ctrl K

AI Score

Unlock

Quince Therapeutics Inc. (QNCX)

AI Score

Unlock

1.46

0.01 (0.69%)

At close: Mar 03, 2025, 3:59 PM

1.43

-1.99%

After-hours: Mar 03, 2025, 06:13 PM EST

Quince Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	322K	175K	344K	332K	188K	51K	45K
Gross Profit	-322K	-175K	-344K	-332K	-188K	-51K	-45K
Operating Income	-34.62M	-52.02M	-90.32M	-78.89M	-39.17M	-12.12M	-10.37M
Interest Income	3.48M	1.07M	620K	2.04M	2.19M	806K	n/a
Pretax Income	-31.58M	-51.94M	-89.94M	-76.85M	-36.98M	-12.48M	-12.23M
Net Income	-31.39M	-51.66M	-89.33M	-76.85M	-36.79M	-12.48M	-12.23M
Selling & General & Admin	15.39M	26.01M	29.52M	17.59M	8.95M	2.03M	1.27M
Research & Development	9.45M	25.18M	60.8M	61.31M	30.21M	10.09M	9.1M
Other Expenses	9.78M	-997K	-247K	n/a	n/a	n/a	n/a
Operating Expenses	34.62M	51.19M	90.32M	78.89M	39.17M	12.12M	10.37M
Interest Expense	n/a	568K	n/a	n/a	n/a	957K	1.64M
Selling & Marketing Expenses	-2.3M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	34.62M	51.19M	90.32M	78.89M	39.17M	12.12M	10.37M
Income Tax	-197K	-284K	-620K	2.17M	-188K	357K	1.86M
Shares Outstanding (Basic)	37.24M	33.5M	29.72M	29.18M	19.03M	21.55M	21.55M
Shares Outstanding (Diluted)	37.24M	33.5M	29.72M	29.18M	19.03M	21.55M	21.55M
EPS (Basic)	-0.84	-1.54	-3.01	-2.63	-1.93	-0.58	-0.57
EPS (Diluted)	-0.84	-1.54	-3.01	-2.63	-1.93	-0.58	-0.57
EBITDA	-31.26M	-52.02M	-89.97M	-78.56M	-38.98M	-12.07M	-10.32M
Depreciation & Amortization	322K	175K	344K	332K	188K	51K	45K